Xcout IntelSign inSubscribe

MaxCyte, Inc. competitors & alternatives

MXCTBiotechRockville, United States

The 12 closest competitors and alternatives to MaxCyte, Inc. among biotech companies — ranked by similarity to what MaxCyte, Inc. actually does, not by market-cap band.

$107.3MMarket cap
91Employees
12Competitors listed

Subscribe to see MaxCyte, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About MaxCyte, Inc.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

MaxCyte, Inc. at a glance

MaxCyte, Inc. is a biotech company headquartered in Rockville, United States. It is publicly listed (MXCT) with a market capitalisation of $107.3M. Xcout tracks 16 named people at MaxCyte, Inc., including Maher Masoud (President, Chief Executive Officer & Executive Director). Xcout recorded 1 job posting from MaxCyte, Inc. in the last 90 days.

MaxCyte, Inc. leadership

  • Maher MasoudPresident, Chief Executive Officer & Executive Director
  • Parmeet AhujaChief Financial Officer
  • Jay GelfmanChief Operations Officer
  • Sidharth KapileshwarChief Corporate Development Officer
  • Ana-Paula Martins FernandesSenior Vice President of Global Sales
  • Jack HorganSenior Vice President of Corporate Development

10 more named people on record for MaxCyte, Inc., with roles, board committees and tenure — see the full roster →

Hiring at MaxCyte, Inc.

Xcout recorded 1 job posting from MaxCyte, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see MaxCyte, Inc.'s hiring signals →

Top 12 MaxCyte, Inc. competitors

Ranked by semantic similarity — how close each company is to MaxCyte, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Codexis, Inc.CDXS · BiotechRedwood City, United States
61% matchPublic

Similar biotech company

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Market cap$157M
Employees188
Codexis, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of MaxCyte, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for MaxCyte, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →